Translation of "laboratoire de santé de l'inrs " (French → English) :

2. The grants referred to in paragraph 1 may be awarded to a single national reference laboratory in each Member State for each European Union reference laboratory for plant health, up to three years after the designation of that European Union reference laboratory'.

13. Supports the establishment of an EU Reference Laboratory (EURL) for bee health, with a view to gaining a better understanding of the factors affecting bee health and how to tackle them effectively, by improving coordination and harmonising monitoring and research programmes for apiculture, including beekeeping associations carried out in Member States; requests that the Commission actively encourage a greater degree of information-sharing between Member States, laboratories and beekeepers on eco-toxicological studies and other factors affecting honeybee health and ensure free access to the ecotoxicological studies included in applic ...[+++]ations for authorisation, to enable informed and independent scientific scrutiny; calls for independent and timely research into bee mortality;

7. Welcomes the establishment of the EU reference laboratory for bee health, which should focus on activities not covered by existing expert networks or national laboratories, and synthesise the integrated knowledge stemming from their research;

1.1.1. Develop strategies and mechanisms for preventing, exchanging information on and responding to health threats from communicable and non-communicable diseases and health threats from physical, chemical or biological sources, including deliberate release acts; take action to ensure high-quality diagnostic cooperation between Member States’ laboratories; support the work of existing laboratories carrying out work with relevance to the Community; work on the setting up of a network of Community reference laboratories.

Moreover, it will support Community preparedness planning, strengthening links with and between the clinical and public health sectors, reinforcing the public health laboratory capacity for rapid diagnosis and supporting and coordinating training programmes.

1. Where it is considered necessary for reasons of human or animal health, a Member State may require the holder of a marketing authorisation for a live vaccine, or for a veterinary immunological medicinal product for a disease that is subject to preventive Community measures, to submit samples of batches of the bulk product and/or veterinary medicinal product for control by a national laboratory or a laboratory approved by the Member State before the product is put into circulation.